Curable compositions and membranes

US9259685B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9259685-B2
Application numberUS-201514603524-A
CountryUS
Kind codeB2
Filing dateJan 23, 2015
Priority dateDec 16, 2009
Publication dateFeb 16, 2016
Grant dateFeb 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A curable composition comprising: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 12 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and a cationic group; (iii) 10 to 70 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; and (v) non-curable salt; wherein the molar ratio of (i):(ii) is >0.10. The compositions are useful for preparing ion exchange membranes.

First claim

Opening claim text (preview).

The invention claimed is: 1. A membrane obtained from a process comprising the following steps: applying a curable composition to a support; and curing the composition to form a membrane; wherein the curable composition comprises: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 12 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and a cationic group; (iii) 10 to 70 wt % solvent; (iv) 0 to 10 wt % of free radical initiator; and (v) non-curable salt comprising a cation and an anion, wherein the anion is not sulfate; wherein the molar ratio of (i):(ii) is greater than and less than 5 0.10. 2. The membrane according to claim 1 wherein the total wt % of components (i) and (ii) relative to the total weight of the composition is 30 to 88 wt %. 3. The membrane according to claim 1 comprising 2 to 50 wt % of non-curable salt as component (v). 4. The membrane according to claim 1 wherein the molar ratio of (i):(ii) is at least 0.15 and which comprises 20 to 65 wt % of component (ii). 5. The membrane according to claim 1 wherein the solvent comprises water and a water-miscible organic solvent. 6. The membrane according to claim 1 which comprises 0.005 to 10 wt % photoinitiator as component (iv). 7. The membrane according to claim 1 which is free from ethylenically unsaturated compounds other than components (i) and (ii). 8. The membrane according to claim 1 wherein the ethylenically unsaturated group is an acrylamide or a methacrylamide group. 9. The membrane according to claim 1 wherein the composition comprises: (i) 5 to 35 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and a cationic group; and (iii) 16 to 45 wt % solvent; (iv) 0.01 to 2 wt % of photoinitiator; and (v) 3 to 40 wt % of non-curable salt comprising a cation and an anion, wherein the anion is not sulfate; wherein the molar ratio of (i):(ii) is at least 0.15. 10. The membrane according to claim 1 wherein the molar ratio of (i):(ii) is at least 0.15 and less than 1.5. 11. The membrane according to claim 1 wherein the composition is cured by irradiation with an electron beam or UV light for a period of less than 30 seconds. 12. The membrane according to claim 1 wherein the curable composition is applied continuously to a moving support using a manufacturing unit comprising a curable composition application station, an irradiation source for curing the composition, and a membrane collecting station and wherein the support moves from the curable composition application station to the irradiation source and to the membrane collecting station. 13. The membrane according to claim 9 wherein the molar ratio of (i):(ii) is less than 1.5.

Assignees

Inventors

Classifications

  • Dialytic cells or batteries; Reverse electrodialysis cells or batteries · CPC title

  • electrodeionisation · CPC title

  • Capacitive deionisation · CPC title

  • by chemical reactions (in-situ polymerisation, polycondensation, cross-linking or reaction for manufacturing composite membranes B01D69/125) · CPC title

  • by chemical reactions, e.g. in situ polymerisation or in situ crosslinking · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9259685B2 cover?
A curable composition comprising: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 12 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and a cationic group; (iii) 10 to 70 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; and (v) non-curable salt; wherein the molar ratio of (i):(ii) is >0.10. The …
Who is the assignee on this patent?
Fujifilm Mfg Europe Bv
What technology area does this patent fall under?
Primary CPC classification B01D61/44. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).